Cancer Research Funding Press Releases
Dr. Karen E. Knudsen, CEO of the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) issued the following statement in response to the announced retirement of the National Institutes of Health Director, Dr. Francis Collins.
Nearly 700 cancer advocates, including patients, survivors and their loved ones, from all 50 states and territories and nearly every congressional district will dial into calls and log onto virtual meetings this week to ask members of Congress to make the fight against cancer a national priority
This year roughly 10,240 Idahoans will be diagnosed with cancer. Thanks in part to advances in cancer research and treatment, we are saving more lives than ever.
Washington, D.C.— The DIVERSE Trials Act, introduced in both the House and Senate would increase diversity in clinical trials and make it easier for all cancer patients to participate in clinical trials. The bipartisan bicameral legislation, sponsored by Sens.
Today the U.S. House of Representatives will begin debate on a package of funding bills for FY 2022, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).
Washington, D.C.---Today the House Appropriations Committee will vote on a proposed FY 2022 spending bill that would increase funding for the National Institutes of Health (NIH) by $6.5 billion and include a $432 million increase for the National Cancer Institute (NCI), and $194 million for the Cancer Moonshot.
ACS CAN applauds new investment in New Jersey Commission on Cancer Research.
AUSTIN, TX – June 23, 2021 – With Gov.
The Biden administration released its budget for FY 22 late last week. Included in the budget is an additional $9 billion in funding for the National Institutes of Health (NIH), including $6.5 for the creation of a new department within the NIH called the Advanced Research Project Agency on Health (ARPA-H).
The American Cancer Society Cancer Action Network (ACS CAN) and the HL7 FHIR Accelerator™ Common Oncology Data Elements eXtensions (CodeX) are working together with partners on a project to increase and expand patient enrollment in cancer clinical trials at smaller and non-research oriented medical centers.